These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38883416)

  • 1. Recent Research Progress on the Use of Transcranial Magnetic Stimulation in the Treatment of Vascular Cognitive Impairment.
    Li S; Xiao Z
    Neuropsychiatr Dis Treat; 2024; 20():1235-1246. PubMed ID: 38883416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and Treatment of Vascular Cognitive Impairment by Transcranial Magnetic Stimulation.
    Cantone M; Lanza G; Fisicaro F; Pennisi M; Bella R; Di Lazzaro V; Di Pino G
    Neural Plast; 2020; 2020():8820881. PubMed ID: 33193753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular Cognitive Impairment through the Looking Glass of Transcranial Magnetic Stimulation.
    Lanza G; Bramanti P; Cantone M; Pennisi M; Pennisi G; Bella R
    Behav Neurol; 2017; 2017():1421326. PubMed ID: 28348458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.
    Gorelick PB; Scuteri A; Black SE; Decarli C; Greenberg SM; Iadecola C; Launer LJ; Laurent S; Lopez OL; Nyenhuis D; Petersen RC; Schneider JA; Tzourio C; Arnett DK; Bennett DA; Chui HC; Higashida RT; Lindquist R; Nilsson PM; Roman GC; Sellke FW; Seshadri S;
    Stroke; 2011 Sep; 42(9):2672-713. PubMed ID: 21778438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between Motor Cortex Excitability Changes and Cognitive Impairment in Vascular Depression: Pathophysiological Insights from a Longitudinal TMS Study.
    Pennisi M; Lanza G; Cantone M; Ricceri R; Spampinato C; Pennisi G; Di Lazzaro V; Bella R
    Neural Plast; 2016; 2016():8154969. PubMed ID: 27525127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementia.
    Di Lazzaro V; Bella R; Benussi A; Bologna M; Borroni B; Capone F; Chen KS; Chen R; Chistyakov AV; Classen J; Kiernan MC; Koch G; Lanza G; Lefaucheur JP; Matsumoto H; Nguyen JP; Orth M; Pascual-Leone A; Rektorova I; Simko P; Taylor JP; Tremblay S; Ugawa Y; Dubbioso R; Ranieri F
    Clin Neurophysiol; 2021 Oct; 132(10):2568-2607. PubMed ID: 34482205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of multi-omics and network pharmacology to explain traditional chinese medicine for vascular cognitive impairment: A narrative review.
    Lv S; Wang Q; Zhang X; Ning F; Liu W; Cui M; Xu Y
    Phytomedicine; 2024 Jan; 123():155231. PubMed ID: 38007992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shengyu Decoction treating vascular cognitive impairment by promoting AKT/HIF-1α/VEGF related cerebrovascular generation and ameliorating MAPK/NF-κB mediated neuroinflammation.
    Fang C; Liu J; Feng M; Jia Z; Li Y; Dai Y; Zhu M; Huang B; Liu L; Wei Z; Wang X; Xiao H
    J Ethnopharmacol; 2022 Oct; 296():115441. PubMed ID: 35700854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic circuitry functioning in patients with vascular cognitive impairment--no dementia.
    Bella R; Cantone M; Lanza G; Ferri R; Vinciguerra L; Puglisi V; Pennisi M; Ricceri R; Di Lazzaro V; Pennisi G
    Brain Stimul; 2016; 9(2):225-33. PubMed ID: 26515786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hyperbaric oxygen therapy combined with repetitive transcranial magnetic stimulation on vascular cognitive impairment: a randomised controlled trial protocol.
    Xie W; Chen X; Ma X; Song S; Ma H; You J; Huang C
    BMJ Open; 2023 Nov; 13(11):e073532. PubMed ID: 37963686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in mild vascular cognitive impairment: A multimodal transcranial magnetic stimulation study.
    Cantone M; Fisicaro F; Ferri R; Bella R; Pennisi G; Lanza G; Pennisi M
    PLoS One; 2023; 18(3):e0282751. PubMed ID: 36867595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.
    Battle CE; Abdul-Rahim AH; Shenkin SD; Hewitt J; Quinn TJ
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013306. PubMed ID: 33704781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural network efficiency mediates the association between glymphatic function and cognition in mild VCI: a DTI-ALPS study.
    Song H; Ruan Z; Gao L; Lv D; Sun D; Li Z; Zhang R; Zhou X; Xu H; Zhang J
    Front Aging Neurosci; 2022; 14():974114. PubMed ID: 36466598
    [No Abstract]   [Full Text] [Related]  

  • 14. Vascular cognitive impairment (VCI): Progress towards knowledge and treatment.
    Di Legge S; Hachinski V
    Dement Neuropsychol; 2010; 4(1):4-13. PubMed ID: 29213654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rivastigmine for vascular cognitive impairment.
    Birks J; McGuinness B; Craig D
    Cochrane Database Syst Rev; 2013 May; (5):CD004744. PubMed ID: 23728651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological assessment and cerebral vascular disease: the new standards.
    Godefroy O; ; Leclercq C; Bugnicourt JM; Roussel M; Moroni C; Quaglino V; Beaunieux H; Taillia H; Nédélec-Ciceri C; Bonnin C; Thomas-Anterion C; Varvat J; Aboulafia-Brakha T; Assal F
    Rev Neurol (Paris); 2013 Oct; 169(10):779-85. PubMed ID: 23999023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular cognitive impairment: disease mechanisms and therapeutic implications.
    Levine DA; Langa KM
    Neurotherapeutics; 2011 Jul; 8(3):361-73. PubMed ID: 21556678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical presentations and epidemiology of vascular dementia.
    Smith EE
    Clin Sci (Lond); 2017 Jun; 131(11):1059-1068. PubMed ID: 28515342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application Progress of Resting-State Functional Magnetic Resonance Imaging in Study of Default Mode Network in Patients with Vascular Cognitive Impairment].
    Wang X; Niu Y; Wang J; Chen X; Wan C
    Zhongguo Yi Liao Qi Xie Za Zhi; 2024 Jan; 48(1):51-56. PubMed ID: 38384217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the after-effects of theta burst stimulation on the human auditory cortex with functional imaging.
    Andoh J; Zatorre RJ
    J Vis Exp; 2012 Sep; (67):e3985. PubMed ID: 23007549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.